Moderated by Kevin Davies, PhD, Executive Editor, The CRISPR Journal
Dr. Kevin Davies: In this discussion, we will be talking about getting started with mRNA-based therapeutics. This expert panel will explore mRNA challenges, including usability, stability, and technological limits, sharing insights into developmental considerations for clinic-bound constructs to help researchers better understand the crucial role of characterizing mRNA in the early stages of development. Our guests will share their insights into mRNA construct development for clinical use and consider the importance of mRNA characterization early in the development process.
Offered Free by: TriLink
See All Resources from: TriLink
